We use cookies for a better user experience. Read our Privacy Policy

I Agree

Drug Discovery Outsourcing Market

Drug Discovery Outsourcing Market (Service Type: Biological Services, Chemical Services, Lead Identification & Screening, Lead Optimization, and Others; Drug Type: Small Molecules and Large Molecules; Therapeutic Area: Respiratory System, Anti-infective, Oncology, Cardiovascular, Gastrointestinal, Central Nervous System, and Immunomodulation, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Increasing Competition and Lack of Adequate Resources in Pharmaceutical Sector to Augment Market Growth

Over the past decade, due to increasing competition, players involved in the biotech and pharmaceutical sector are primarily focusing on research and development activities to gain a competitive edge. In addition, economic environment, along with fast-paced developments on the technological front have accelerated internal as well as external innovations in the pharmaceutical space due to which, drug discovery outsourcing has gained considerable traction. External innovations largely occur in various forms at various places, including research laboratories, university labs, contract research organizations, and venture capital-based startups.

Over the past couple of decades, various challenges within the pharmaceutical sector have been well documented and point toward few key areas. The development of new drugs continues to head toward steep costs, the market competition from generics continues to grow, investors expect higher returns, and rising consumer complaints regarding high costs of drugs have led to the growth of the drug discovery outsourcing. This trend is likely to continue during the forecast period. Pharmaceutical companies are increasingly focusing on improving the efficacy of drug development and discovery.

Major developments that are likely to gain considerable traction over the next few years across the drug discovery outsourcing market include a decline in time utilized for drug development, improving the conversion rate of hits to leads, and expanding the number of high-quality compounds. At the back of these factors and evolving economic landscape, the global drug discovery outsourcing market is expected to reach ~US$ 12.7 Bn by the end of 2030.

To know the scope of our report Get a Sample on Drug Discovery Outsourcing Market 

Cost Benefits Associated with Drug Discovery Outsourcing to Increase Adoption

Biotech and pharmaceutical companies have consistently expressed high levels of interest in drug discovery outsourcing due to immense cost saving and various other benefits over in-house manufacturing. As per current trends, the number of small and medium-sized businesses operating in the drug discovery outsourcing market is expected to remain higher than that of larger entities due to the low number of stakeholders and fewer organizational barriers in decision-making. In addition, apart from minimizing organizational complications, small and medium-sized companies are increasingly relying on drug discovery outsourcing for product manufacturing and development due to various factors, including insufficient production ability and lack of technical expertise. These factors, along with mushrooming costs of research and development activities continue to accelerate the overall growth of the global drug discovery outsourcing market.

Challenges in Modern-day Pharmaceutical Sector and Technological Advancements Redefine Drug Development

The modern-day pharmaceutical is marred with several challenges in the drug development phase and requires considerable changes. Due to mounting challenges in drug development, drug development as well as drug discovery activities are increasingly being outsourced. Pricing pressure remains the major factor that is likely to trigger the tectonic shift in drug discovery outsourcing during the forecast period. High profit margins of pharmaceutical companies have attracted the attention of healthcare providers to add pressure pertaining to costs and reimbursement. In addition, as a result, as profit margins continue to decline several companies are evaluating the possibility of outsourcing drug discovery to third party organizations that have been equipped with required resources.

Get a glimpse of the in-depth analysis through our Report Brochure

Technological advancements have played a key role in accelerating innovations in the past decade and the trend is likely to continue in the upcoming decade. Due to fast-paced development in technology, competition in the drug discovery and drug development sectors has increased at a rapid pace. Due to the cutthroat competition, several companies in the drug discovery outsourcing market are increasingly joining hands with third-party companies to develop various cost-effective drugs.

Outsourcing of COVID-19 Drugs on Rise amid Pandemic

The ongoing COVID-19 pandemic is expected to have a low impact on the overall prospects of the global drug discovery outsourcing market. In addition, the outsourcing of drugs and medications required to manage COVID-19 infections is expected to witness considerable growth during the COVID-19 pandemic. Pharmaceutical companies are likely to turn toward domestic players for drug discovery outsourcing rather than businesses based in other regional markets. Logistical challenges, along with trade restrictions could possibly pose a barrier in the supply chain.

In addition, as the number of COVID-19 patients continues to swell around the world, pharmaceutical companies are increasingly relying on drug discovery outsourcing to fulfill the soaring demand. Several companies are expected to invest resources in research and development activities that focus on the discovery of a vaccine for the COVID-19 coronavirus. The ongoing investments in research coupled with high demand for medication to treat COVID-19 patients is expected to play a key role in boosting the growth of the drug discovery outsourcing market during the COVID-19 pandemic.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global drug discovery outsourcing market is expected to grow at an impressive CAGR of 10% during the forecast period. The market growth can be attributed to increase in research and development costs, rise in competition in the pharmaceutical sector, consumer demand for low-cost and efficient medication, and advancements in technology. Small to medium-sized pharmaceutical companies are increasingly turning to drug discovery outsourcing due to lack of adequate production capabilities & resources and lack of expertise. Although several larger companies are also expected to follow a similar path, organizational complications and discrepancies among shareholders could possibly slow down the process.

Drug Discovery Outsourcing Market: Overview

  • The global drug discovery outsourcing market was valued at ~US$ 4.5 Bn in 2019. It is projected to expand at a high CAGR from 2020 to 2030. Drug discovery contract research organizations (CROs) are engaged in offering a range of research services on a contract basis to pharmaceutical and biotechnology companies for drug discovery.
  • Rise in demand for drug discovery outsourcing can be attributed to the increase in focus of pharmaceutical companies on research and development and rise in focus on the development of novel drugs to meet the unmet clinical needs in various therapeutic areas including cancer, neurological disorders, and chronic diseases.

Drug Discovery Outsourcing Market: Segmentation

  • The global drug discovery outsourcing market has been segmented based on service type, drug type, therapeutic area, and region
  • In terms of service type, the global drug discovery outsourcing market has been categorized into biological services, chemical services, lead identification & screening, lead optimization, and others. The chemical services segment dominated the global drug discovery outsourcing market, in terms of value, in 2019. However, the biological services segment is likely to expand at a high CAGR during the forecast period.
  • Based on drug type, the global drug discovery outsourcing market has been classified into small molecules and large molecules. The small molecules segment dominated the drug discovery outsourcing market in 2019 and is likely to remain dominant in the forecast period. In terms of therapeutic area, the global drug discovery outsourcing market has been divided into respiratory system, anti-infective, oncology, cardiovascular, gastrointestinal, central nervous system, immunomodulation, and others. Oncology segment dominated the global drug discovery outsourcing market in 2019.

Drug Discovery Outsourcing Market: Regional Segmentation

  • In terms of region, the global drug discovery outsourcing market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global drug discovery outsourcing market in 2019, and the trend is expected to continue during the forecast period. Expansion of the drug discovery outsourcing market in the region can be attributed to an increase in focus on discovering medicines for the treatment of rise in pandemic, which has resulted in drug discovery outsourcing to companies equipped with AI technology. Additionally, an increase in investments in research & development (R&D) by large pharmaceutical and biotechnology companies and their focus on streamlining internal costs leading to the drug discovery outsourcing process fuels the market.
  • The drug discovery outsourcing market in Asia Pacific is anticipated to expand at a high CAGR from 2020 to 2030. Expansion of the drug discovery outsourcing market in the region can be attributed to an increase in focus of pharmaceutical companies on the region as a favorable site for drug discovery outsourcing processes.

Drug Discovery Outsourcing Market: Major Players

  • Key players operating in the global drug discovery outsourcing market include 
    • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • WuXi AppTec Co., Ltd.
    • Albany Molecular Research Inc. (AMRI)
    • GVK Biosciences Private Limited
    • Sygnature Discovery
    • Pharmaron Beijing Co., Ltd
    • WuXi Biologics (Cayman), Inc.
    • Domainex Ltd.
    • Thermo Fisher Scientific, Inc.
    • Jubilant Biosys Ltd.
    • Evotec SE
    • Eurofins Discovery, 
    • GenScript Biotech Corporation
  • The market players in the drug discovery outsourcing market have been adopting inorganic growth strategies to consolidate their position in the global drug discovery outsourcing market. For instance, in February 2020, Charles River acquired Citoxlab for US$ 510 Mn. Citoxlab is a non-clinical CRO company that specializes in regulated safety assessment services, nonregulated discovery services, and medical device testing. In January 2018, Spectris acquired Concept Life Sciences from Equistone Partners Europe. Concept Life Sciences is the U.K.-based provider of drug discovery, development, analytical testing, and environmental consultancy services drug discovery and development services.

Drug Discovery Outsourcing Market – Segmentation

Service Type

Biological Services

Chemical Services

Lead Identification & Screening

Lead Optimization

Others

Drug Type

Small Molecules

Large Molecules

Therapeutic Area

Respiratory System

Anti-infective

Oncology

Cardiovascular

Gastrointestinal

Central Nervous System

Immunomodulation

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of Drug Discovery Outsourcing Market?

Drug discovery outsourcing market is expected to reach ~US$ 12.7 Bn by the end of 2030

Which region is expected to project the highest market share in the global Drug Discovery Outsourcing Market?

North America dominated the global drug discovery outsourcing market in 2019, and the trend is expected to continue during the forecast period

What are the key driving factors for the growth of the Drug Discovery Outsourcing Market?

Drug Discovery Outsourcing Market is driven by rise in penetration of contract research organizations for pre-clinical research, increase in investments in research and development (R&D) and a surge in the demand for personalized medicines

Which is the rising prominent segment in the Drug Discovery Outsourcing Market?

The small molecules segment is anticipated to account for a major share of the global drug discovery outsourcing market during the forecast period

Who are the key players in the global Drug Discovery Outsourcing Market?

Key players operating in the global drug discovery outsourcing market are CHARLES RIVER LABORATORIES INTERNATIONAL, INC., WuXi AppTec Co., Ltd., Albany Molecular Research Inc. (AMRI), GVK Biosciences Private Limited, Sygnature Discovery

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Drug Discovery Outsourcing Market

    4. Market Overview

        4.1. Definition

        4.2. Market Indicators

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

        4.5. Global Drug Discovery Outsourcing Market Outlook

    5. Key Insights

        5.1. Key Mergers & Acquisition

        5.2. Technological Advancements in Drug Discovery

        5.3. Drug Discovery Process – an Overview

        5.4. COVID-19 Pandemics Impact on Drug Discovery Outsourcing Industry

        5.5. Overview of Companies outsourcing to CROs

        5.6. Overview: Integrated Drug Discovery (IDD) outsourcing- trends, competition, business models preferred, type of projects outsourced

    6. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Service Type 

        6.1. Introduction 

        6.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type

        6.3. Global Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

            6.3.1. Biological Services

            6.3.2. Chemical Services

            6.3.3. Lead Identification & Screening

            6.3.4. Lead Optimization

            6.3.5. Others

        6.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type 

    7. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Drug Type

        7.1. Introduction 

        7.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type

        7.3. Global Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

            7.3.1. Small Molecules

            7.3.2. Large Molecules

        7.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type

    8. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Therapeutic Area

        8.1. Introduction 

        8.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area

        8.3. Global Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

            8.3.1. Respiratory System

            8.3.2. Anti-infective

            8.3.3. Oncology

            8.3.4. Cardiovascular

            8.3.5. Gastrointestinal

            8.3.6. Central Nervous System

            8.3.7. Immunomodulation

            8.3.8. Others

        8.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area

    9. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Region 

        9.1. Regional Outlook

        9.2. Introduction

        9.3. Global Drug Discovery Outsourcing Market Value Forecast, by Region

            9.3.1. North America

            9.3.2. Europe 

            9.3.3. Asia Pacific

            9.3.4. Latin America 

            9.3.5. Middle East & Africa

        9.4.  Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region

    10. North America Drug Discovery Outsourcing Market Analysis and Forecast

        10.1.  Key Findings

        10.2.  North America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

            10.2.1. Biological Services

            10.2.2. Chemical Services

            10.2.3. Lead Identification & Screening

            10.2.4. Lead Optimization

            10.2.5. Others 

        10.3. North America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

            10.3.1. Small Molecules 

            10.3.2. Large Molecules

        10.4. North America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

            10.4.1. Respiratory System

            10.4.2. Anti-infective

            10.4.3. Oncology

            10.4.4. Cardiovascular

            10.4.5. Gastrointestinal

            10.4.6. Central Nervous System

            10.4.7. Immunomodulation

            10.4.8. Others

        10.5. North America Drug Discovery Outsourcing Market Value Forecast, by Country, 2018–2030

            10.5.1. U.S.

            10.5.2. Canada

        10.6. North America Drug Discovery Outsourcing Market Attractiveness Analysis

            10.6.1. By Service Type

            10.6.2. By Drug Type

            10.6.3. By Therapeutic Area

            10.6.4. By Country

    11. Europe Drug Discovery Outsourcing Market Analysis and Forecast

        11.1.  Key Findings

        11.2.  Europe Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

            11.2.1. Biological Services

            11.2.2. Chemical Services

            11.2.3. Lead Identification & Screening

            11.2.4. Lead Optimization

            11.2.5. Others 

        11.3. Europe Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

            11.3.1. Small Molecules 

            11.3.2. Large Molecules

        11.4. Europe Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

            11.4.1. Respiratory System

            11.4.2. Anti-infective

            11.4.3. Oncology

            11.4.4. Cardiovascular

            11.4.5. Gastrointestinal

            11.4.6. Central Nervous System

            11.4.7. Immunomodulation

            11.4.8. Others

        11.5. Europe Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

            11.5.1. U.K.

            11.5.2. Germany

            11.5.3. France

            11.5.4. Italy 

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Europe Drug Discovery Outsourcing Market Attractiveness Analysis

            11.6.1. By Service Type

            11.6.2. By Drug Type

            11.6.3. By Therapeutic Area

            11.6.4. By Country/Sub-region

    12. Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast

        12.1.  Key Findings

        1.1. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

            12.1.1. Biological Services

            12.1.2. Chemical Services

            12.1.3. Lead Identification & Screening

            12.1.4. Lead Optimization

            12.1.5. Others 

        12.2. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

            12.2.1. Small Molecules 

            12.2.2. Large Molecules

        12.3. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

            12.3.1. Respiratory System

            12.3.2. Anti-infective

            12.3.3. Oncology

            12.3.4. Cardiovascular

            12.3.5. Gastrointestinal

            12.3.6. Central Nervous System

            12.3.7. Immunomodulation

            12.3.8. Others

        12.4. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

            12.4.1. China

            12.4.2. India

            12.4.3. Japan

            12.4.4. Australia & New Zealand 

            12.4.5. Rest of Asia Pacific 

        12.5. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis

            12.5.1. By Service Type

            12.5.2. By Drug Type

            12.5.3. By Therapeutic Area 

            12.5.4. By Country/Sub-region

    13. Latin America Drug Discovery Outsourcing Market Analysis and Forecast

        13.1.  Key Findings

        13.2. Latin America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

            13.2.1. Biological Services

            13.2.2. Chemical Services

            13.2.3. Lead Identification & Screening

            13.2.4. Lead Optimization

            13.2.5. Others 

        13.3. Latin America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

            13.3.1. Small Molecules 

            13.3.2. Large Molecules

        13.4. Latin America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

            13.4.1. Respiratory System

            13.4.2. Anti-infective

            13.4.3. Oncology

            13.4.4. Cardiovascular

            13.4.5. Gastrointestinal

            13.4.6. Central Nervous System

            13.4.7. Immunomodulation

            13.4.8. Others

        13.5. Latin America Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

            13.5.1. Brazil 

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis

            13.6.1. By Service Type

            13.6.2. By Drug Type

            13.6.3. By Therapeutic Area

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Drug Discovery Outsourcing Market Analysis and Forecast

        14.1.  Key Findings

        14.2. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

            14.2.1. Biological Services

            14.2.2. Chemical Services

            14.2.3. Lead Identification & Screening

            14.2.4. Lead Optimization

            14.2.5. Others 

        14.3. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

            14.3.1. Small Molecules 

            14.3.2. Large Molecules

        14.4. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

            14.4.1. Respiratory System

            14.4.2. Anti-infective

            14.4.3. Oncology

            14.4.4. Cardiovascular

            14.4.5. Gastrointestinal

            14.4.6. Central Nervous System

            14.4.7. Immunomodulation

            14.4.8. Others

        14.5. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

            14.5.1. GCC Countries 

            14.5.2. South Africa 

            14.5.3. Rest of Middle East & Africa

        14.6. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis

            14.6.1. By Service Type

            14.6.2. By Drug Type

            14.6.3. By Therapeutic Area

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1.  Market Player - Competition Matrix (by tier and size of companies)

        15.2.  Market Share Analysis, by Company, 2019

        15.3. Company Profiles

            15.3.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.  

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Financial Overview

                15.3.1.3. Product Portfolio

                15.3.1.4. Strategic Overview

                15.3.1.5. SWOT Analysis

            15.3.2. WuXi AppTec Co., Ltd.

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Financial Overview

                15.3.2.3. Product Portfolio

                15.3.2.4. Strategic Overview

                15.3.2.5. SWOT Analysis

            15.3.3. Albany Molecular Research Inc. (AMRI)

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Financial Overview

                15.3.3.3. Product Portfolio

                15.3.3.4. Strategic Overview

                15.3.3.5. SWOT Analysis

            15.3.4. GVK Biosciences Private Limited

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Financial Overview

                15.3.4.3. Product Portfolio

                15.3.4.4. Strategic Overview

                15.3.4.5. SWOT Analysis

            15.3.5. Sygnature Discovery

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Financial Overview

                15.3.5.3. Product Portfolio

                15.3.5.4. Strategic Overview

                15.3.5.5. SWOT Analysis

            15.3.6. Pharmaron Beijing Co., Ltd.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Financial Overview

                15.3.6.3. Product Portfolio

                15.3.6.4. Strategic Overview

                15.3.6.5. SWOT Analysis

            15.3.7. WuXi Biologics (Cayman), Inc.

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Financial Overview

                15.3.7.3. Product Portfolio

                15.3.7.4. Strategic Overview

                15.3.7.5. SWOT Analysis

            15.3.8. Domainex Ltd.

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Financial Overview

                15.3.8.3. Product Portfolio

                15.3.8.4. Strategic Overview

                15.3.8.5. SWOT Analysis

            15.3.9. Thermo Fisher Scientific, Inc.

                15.3.9.1.  Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Financial Overview

                15.3.9.3. Product Portfolio

                15.3.9.4. Strategic Overview

                15.3.9.5. SWOT Analysis

            15.3.10.  Jubilant Biosys Ltd.

                15.3.10.1.  Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Financial Overview

                15.3.10.3. Product Portfolio

                15.3.10.4. Strategic Overview

                15.3.10.5. SWOT Analysis

            15.3.11.  Evotec SE

                15.3.11.1.  Company Overview (HQ, Business Segments, Employee Strength)

                15.3.11.2. Financial Overview

                15.3.11.3. Product Portfolio

                15.3.11.4. Strategic Overview

                15.3.11.5. SWOT Analysis

            15.3.12.  Eurofins Discovery

                15.3.12.1.  Company Overview (HQ, Business Segments, Employee Strength)

                15.3.12.2. Financial Overview

                15.3.12.3. Product Portfolio

                15.3.12.4. Strategic Overview

                15.3.12.5. SWOT Analysis

            15.3.13.  GenScript Biotech Corporation

                15.3.13.1.  Company Overview (HQ, Business Segments, Employee Strength)

                15.3.13.2. Financial Overview

                15.3.13.3. Product Portfolio

                15.3.13.4. Strategic Overview

                15.3.13.5. SWOT Analysis

    List of Tables

    Table 01: Companies entering into partnerships with CROs for drug discovery

    Table 02: Integrated Drug Discovery – Key Players

    Table 03: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

    Table 04: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

    Table 05: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

    Table 06: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Region, 2018–2030

    Table 07: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country, 2018–2030

    Table 08: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

    Table 09: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

    Table 10: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

    Table 11: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    Table 12: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

    Table 13: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

    Table 14: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

    Table 15: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    Table 16: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

    Table 17: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

    Table 18: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

    Table 19: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    Table 20: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

    Table 21: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

    Table 22: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

    Table 23: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    Table 24: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

    Table 25: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

    Table 26: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

    List of Figures

    Figure 01: Global Drug Discovery Outsourcing Market

    Figure 02: Global Drug Discovery Outsourcing Market Size (US$ Mn) Forecast, 2018–2030

    Figure 03: Global Drug Discovery Outsourcing market Value Share, by Service Type, 2020

    Figure 04: Global Drug Discovery Outsourcing Market Value Share, by Drug Type, 2020

    Figure 05: Global Drug Discovery Outsourcing Market Value Share, by Therapeutic Area, 2020

    Figure 06: Global Drug Discovery Outsourcing Market Value Share, by Region, 2020

    Figure 07: CRO Services Market – Key Mergers and Acquisitions

    Figure 08: Technological Advancements in Drug Discovery

    Figure 09: Drug Discovery & Development Process – an Overview 

    Figure 10: Drug Discovery Process – an Overview 

    Figure 11: IDD Trends

    Figure 12: IDD Business Models

    Figure 13: IDD- Types of Projects

    Figure 14: Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

    Figure 15: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

    Figure 16: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biological Services, 2018–2030

    Figure 17: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chemical Services, 2018–2030

    Figure 18: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Identification & Screening, 2018–2030

    Figure 19: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Optimization, 2018–2030

    Figure 20: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

    Figure 21: Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

    Figure 22: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020–2030

    Figure 23: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Small Molecules, 2018–2030

    Figure 24: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Large Molecules, 2018–2030

    Figure 25: Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

    Figure 26: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020–2030

    Figure 27: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Respiratory System, 2018–2030

    Figure 28: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anti-infective, 2018–2030

    Figure 29: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oncology, 2018–2030

    Figure 30: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiovascular, 2018–2030

    Figure 31: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gastrointestinal, 2018–2030

    Figure 32: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Central Nervous System, 2018–2030

    Figure 33: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Immunomodulation, 2018–2030

    Figure 34: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

    Figure 35: Global Drug Discovery Outsourcing Market: Regional Outlook

    Figure 36: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

    Figure 37: Global Drug Discovery Outsourcing Market Value Share Analysis, by Region, 2019 and 2030

    Figure 38: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region, 2020–2030

    Figure 39: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

    Figure 40: North America Drug Discovery Outsourcing Market Value Share Analysis, by Country, 2019 and 2030

    Figure 41: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country, 2020–2030

    Figure 42: North America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

    Figure 43: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

    Figure 44: North America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

    Figure 45: North America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

    Figure 46: North America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

    Figure 47: North America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

    Figure 48: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

    Figure 49: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

    Figure 50: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 51: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

    Figure 52: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

    Figure 53: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

    Figure 54: Europe Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

    Figure 55: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

    Figure 56: Europe Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

    Figure 57: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

    Figure 58: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

    Figure 59: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 60: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

    Figure 61: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

    Figure 62: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

    Figure 63: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020–2030

    Figure 64: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

    Figure 65: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020–2030

    Figure 66: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

    Figure 67: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

    Figure 68: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 69: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

    Figure 70: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

    Figure 71: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

    Figure 72: Latin America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

    Figure 73: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

    Figure 74: Latin America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

    Figure 75: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

    Figure 76: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

    Figure 77: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 78: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

    Figure 79: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

    Figure 80: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

    Figure 81: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

    Figure 82: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

    Figure 83: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

    Figure 84: Global Drug Discovery Outsourcing Market Analysis, by Top Company Ranking, 2019

Google translate

Copyright © Transparency Market Research, Inc. All Rights reserved